Innovative Pharmaceutical Biotech Limited (HKG:0399)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.2050
-0.0070 (-3.30%)
Jun 13, 2025, 4:08 PM HKT

HKG:0399 Cash Flow Statement

Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2015 - 2019
Net Income
11.46103.4-245.745.8-204.94-211.12
Upgrade
Depreciation & Amortization
0.190.941.882.132.311.24
Upgrade
Loss (Gain) From Sale of Assets
-----0.29-
Upgrade
Loss (Gain) From Sale of Investments
-----5.27
Upgrade
Loss (Gain) on Equity Investments
------6.31
Upgrade
Provision & Write-off of Bad Debts
-0.07-0.07-0.18-0.080.070.23
Upgrade
Other Operating Activities
-22.39-116.84225-70.07183.85179.62
Upgrade
Change in Accounts Receivable
1.331.333.276.140.215.34
Upgrade
Change in Accounts Payable
-2.17-2.17-4.132.67-4.77-10.96
Upgrade
Change in Other Net Operating Assets
5.125.122.221.07-1.440.47
Upgrade
Operating Cash Flow
-6.53-8.28-17.64-12.34-25.01-36.22
Upgrade
Sale of Property, Plant & Equipment
----0.01-
Upgrade
Investment in Securities
-----50
Upgrade
Other Investing Activities
----0--0.02
Upgrade
Investing Cash Flow
----00.0149.98
Upgrade
Short-Term Debt Issued
-11.316.8820137
Upgrade
Long-Term Debt Issued
-----9.8
Upgrade
Total Debt Issued
6.511.316.88201316.8
Upgrade
Short-Term Debt Repaid
------25
Upgrade
Long-Term Debt Repaid
--0.97-1.88-12.62-2.3-1.16
Upgrade
Total Debt Repaid
-0.04-0.97-1.88-12.62-2.3-26.16
Upgrade
Net Debt Issued (Repaid)
6.4610.33157.3810.7-9.36
Upgrade
Other Financing Activities
-0-0.01-0.08-0.08-0.13-0.12
Upgrade
Financing Cash Flow
6.4510.3214.927.310.57-9.48
Upgrade
Foreign Exchange Rate Adjustments
-0.32-0.3-0.030.130.481.6
Upgrade
Net Cash Flow
-0.391.74-2.75-4.91-13.945.88
Upgrade
Free Cash Flow
-6.53-8.28-17.64-12.34-25.01-36.22
Upgrade
Free Cash Flow Margin
-110.79%-125.57%-218.45%-110.68%-164.63%-248.45%
Upgrade
Free Cash Flow Per Share
-0.00-0.00-0.01-0.01-0.02-0.03
Upgrade
Cash Interest Paid
00.010.080.080.130.12
Upgrade
Levered Free Cash Flow
-128.15-139.59-156.25-121.96-139.37-115.74
Upgrade
Unlevered Free Cash Flow
-1.37-3.28-10.02-3.24-19.98-23.84
Upgrade
Change in Net Working Capital
-7.43-4.21-1.18-9.98.794.86
Upgrade
Updated Dec 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.